Home Cart 0 Sign in  
X

[ CAS No. 405174-97-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 405174-97-2
Chemical Structure| 405174-97-2
Chemical Structure| 405174-97-2
Structure of 405174-97-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 405174-97-2 ]

Related Doc. of [ 405174-97-2 ]

Alternatived Products of [ 405174-97-2 ]

Product Details of [ 405174-97-2 ]

CAS No. :405174-97-2 MDL No. :MFCD07781220
Formula : C6H4BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :DCOPXKMVVJNPSW-UHFFFAOYSA-N
M.W : 186.01 Pubchem ID :16414231
Synonyms :

Calculated chemistry of [ 405174-97-2 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 37.32
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.48 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.14
Log Po/w (XLOGP3) : 1.34
Log Po/w (WLOGP) : 1.66
Log Po/w (MLOGP) : 0.56
Log Po/w (SILICOS-IT) : 2.2
Consensus Log Po/w : 1.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.26
Solubility : 1.01 mg/ml ; 0.00544 mol/l
Class : Soluble
Log S (Ali) : -1.57
Solubility : 5.0 mg/ml ; 0.0269 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.83
Solubility : 0.278 mg/ml ; 0.00149 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.19

Safety of [ 405174-97-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 405174-97-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 405174-97-2 ]
  • Downstream synthetic route of [ 405174-97-2 ]

[ 405174-97-2 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 405174-97-2 ]
  • [ 253-69-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 7, p. 2989 - 3004
  • 2
  • [ 2999-46-4 ]
  • [ 405174-97-2 ]
  • [ 17288-32-3 ]
Reference: [1] Journal of the Brazilian Chemical Society, 2011, vol. 22, # 11, p. 2036 - 2039
  • 3
  • [ 405174-97-2 ]
  • [ 52378-64-0 ]
YieldReaction ConditionsOperation in experiment
99% With sodium tetrahydroborate In tetrahydrofuran; methanol at 0 - 20℃; for 4 h; (3-Bromopyridin-2-yl)methanol (B5.2) (0363) To a mixture of B5.1 (1 g, 5.4 mmol) in MeOH (20 mL) and THF (10 mL) was cooled to 0° C., NaBH4 (0.82 g, 21.6 mmol) was added in portions. The mixture was stirred for 4 h at rt. The mixture was concentrated, diluted with water (40 mL), extracted with DCM (40 mL×3), the organic layer was washed with brine, dried over Na2SO4, filtered and concentrated to give the title compound (1 g, 99percent) as a white solid. LC-MS: [M+H]+=190.0.
99% With methanol; sodium tetrahydroborate In tetrahydrofuran at 0 - 20℃; for 4 h; To a mixture of B5.1 (1 g, 5.4 mmol) in MeQH (20 mL) and THF (10 mL) was cooled to 0°C, NaBH4 (0.82 g, 21.6 mmol) wasadded in portions. The mixture was stirred for 4 h at it The mixture was concentrated, diluted with water (40 mL), extracted with DCM (40 mL x 3), the organic layer was washed with brine, dried over Na2SQ4, filtered and concentrated to give the title compound (1 g, 99percent) as a white solid. LC-MS: [M+H] = 190.0.
82% With methanol; sodium tetrahydroborate In tetrahydrofuran at 0℃; for 4 h; A mixture of B6.1 (480 mg, 2.58 mmol ) in MeOH(10 mL) and THF(5 mL) was cooled to 0 oC , NaBH4 (390 mg, 10.32 mmol) was added in portions .The mixture was stirred for 4 h, then concentrated, and diluted with water(30 mL), extracted with DCM (30 mL × 3). The organic layer was washed with brine (30 mL), dried over Na2SO4, concentrated to give the title compound (400 mg, 82percent) as a white solid. LC-MS: [MH]+ = 188.0.
Reference: [1] Patent: US2016/176882, 2016, A1, . Location in patent: Paragraph 0361; 0363
[2] Patent: WO2017/221100, 2017, A1, . Location in patent: Paragraph 00171
[3] Patent: WO2017/221092, 2017, A1, . Location in patent: Paragraph 00169
  • 4
  • [ 38749-79-0 ]
  • [ 405174-97-2 ]
YieldReaction ConditionsOperation in experiment
63% With selenium(IV) oxide In 1,4-dioxane for 48 h; Reflux Dissolve 3-bromo-2-methylpyridine (258 mg, 1.5 mmol) in dioxane (5 mL) and add selenium dioxide while stirring (666 mg, 6.0 mmol), the mixture was refluxed for 48 h, allowed to cool, and the filtrate was concentrated. The residue was purified by column chromatography to give a pale yellow solid. (175 mg, 63percent yield).
55% With selenium(IV) oxide In 1,4-dioxane at 120℃; for 18 h; 3-Bromopicolinaldehyde (B5.1) (0362) A mixture of 3-bromo-2-methylpyridine (5 g, 29 mmol), SeO2 (17.5 mg, 116 mmol) in dioxane (70 mL) was heated to 120° C. and stirred for 18 h. The mixture was concentrated and purified by silica gel (PE:EA=4:1) to give the title compound (3 g, 55percent) as a white solid. LC-MS: [M+H]+=188.1.
55% With selenium(IV) oxide In 1,4-dioxane at 120℃; for 18 h; A mixture of 3-bromo-2-methylpyridine (5 g,2gmmol), SeQ2 (17.5 mg, ll6mmol) in dioxane (70 mL) was heated to 120°C andstirred for 18 h. The mixture was concentrated and purified by silica gel (PE:EA = 4:1)to give the title compound (3 g, 55percent) as a white solid. LC-MS: [M+H] = 188.1.
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 6, p. 1239 - 1245
[2] Patent: CN103570683, 2018, B, . Location in patent: Paragraph 0687; 0691-0694
[3] Patent: US2016/176882, 2016, A1, . Location in patent: Paragraph 0361; 0362
[4] Patent: WO2017/221100, 2017, A1, . Location in patent: Paragraph 00170
[5] Tetrahedron Letters, 2005, vol. 46, # 36, p. 6033 - 6036
[6] Patent: WO2012/177896, 2012, A1,
[7] Patent: WO2012/177893, 2012, A2,
[8] Journal of Medicinal Chemistry, 2014, vol. 57, # 7, p. 2989 - 3004
  • 5
  • [ 13534-89-9 ]
  • [ 68-12-2 ]
  • [ 405174-97-2 ]
Reference: [1] Patent: WO2016/100157, 2016, A2, . Location in patent: Page/Page column 46; 47
[2] Patent: WO2016/89721, 2016, A1, . Location in patent: Page/Page column 36; 37
[3] Patent: WO2016/100161, 2016, A1, . Location in patent: Page/Page column 47
[4] Patent: WO2016/85783, 2016, A1, . Location in patent: Page/Page column 44
  • 6
  • [ 867353-49-9 ]
  • [ 405174-97-2 ]
Reference: [1] Patent: WO2005/100356, 2005, A1, . Location in patent: Page/Page column 53-54
  • 7
  • [ 626-55-1 ]
  • [ 68-12-2 ]
  • [ 405174-97-2 ]
Reference: [1] Angewandte Chemie - International Edition, 2014, vol. 53, # 30, p. 7933 - 7937[2] Angew. Chem., 2014, vol. 126, # 30, p. 8067 - 8071,5
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 405174-97-2 ]

Bromides

Chemical Structure| 111043-09-5

[ 111043-09-5 ]

1-(3-Bromopyridin-2-yl)ethanone

Similarity: 0.88

Chemical Structure| 38749-79-0

[ 38749-79-0 ]

3-Bromo-2-methylpyridine

Similarity: 0.84

Chemical Structure| 30683-23-9

[ 30683-23-9 ]

3-Bromopyridine-2-carboxylic acid

Similarity: 0.83

Chemical Structure| 1060815-64-6

[ 1060815-64-6 ]

3-Bromo-6-chloropicolinaldehyde

Similarity: 0.82

Chemical Structure| 754131-60-7

[ 754131-60-7 ]

3-Bromo-2-(bromomethyl)pyridine

Similarity: 0.81

Aldehydes

Chemical Structure| 1060815-64-6

[ 1060815-64-6 ]

3-Bromo-6-chloropicolinaldehyde

Similarity: 0.82

Chemical Structure| 131747-63-2

[ 131747-63-2 ]

4-Bromopicolinaldehyde

Similarity: 0.78

Chemical Structure| 1196157-14-8

[ 1196157-14-8 ]

4-Bromo-5-methylpicolinaldehyde

Similarity: 0.77

Chemical Structure| 113118-81-3

[ 113118-81-3 ]

5-Bromonicotinaldehyde

Similarity: 0.74

Chemical Structure| 1121-60-4

[ 1121-60-4 ]

2-Pyridinecarboxaldehyde

Similarity: 0.72

Related Parent Nucleus of
[ 405174-97-2 ]

Pyridines

Chemical Structure| 111043-09-5

[ 111043-09-5 ]

1-(3-Bromopyridin-2-yl)ethanone

Similarity: 0.88

Chemical Structure| 38749-79-0

[ 38749-79-0 ]

3-Bromo-2-methylpyridine

Similarity: 0.84

Chemical Structure| 30683-23-9

[ 30683-23-9 ]

3-Bromopyridine-2-carboxylic acid

Similarity: 0.83

Chemical Structure| 1060815-64-6

[ 1060815-64-6 ]

3-Bromo-6-chloropicolinaldehyde

Similarity: 0.82

Chemical Structure| 754131-60-7

[ 754131-60-7 ]

3-Bromo-2-(bromomethyl)pyridine

Similarity: 0.81